ArticleProceedings (Baylor University. Medical Center)2026
The burden and outcomes of vaccine-preventable infections among adult congenital heart disease patients: a nationwide analysis.
Article in Proceedings (Baylor University. Medical Center), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundComorbidities increase the risk of adverse outcomes from infections. This study aimed to assess the prevalence and outcomes of vaccine-preventable infections (VPI) in adult congenital heart disease (ACHD) patients compared to the general population.
methodsUsing the 2016-2020 National Inpatient Sample database, we identified VPI hospitalizations and compared outcomes between ACHD patients and the general population. The primary study outcome was in-hospital mortality, with secondary outcomes including respiratory failure, acute kidney injury, acute liver failure, septic shock, cardiac arrest, length of stay, and total hospital charges.
resultsOf 647,440 patients hospitalized for VPI, 2610 (0.3%) had ACHD. After adjustment for baseline characteristics, ACHD patients had similar odds of in-hospital mortality (adjusted odds ratio [aOR] 1.12, 95% confidence interval [CI] 0.64-1.98), respiratory failure (aOR 1.05, 95% CI 0.84-1.32), septic shock (aOR 1.03, 95% CI 0.66-1.60), and cardiac arrest (aOR 1.01, 95% CI 0.36-2.74), but higher odds of acute kidney injury (aOR 1.34, 95% CI 1.09-1.67) and acute liver failure (aOR 1.27, CI 1.01-1.60) compared to the general population.
conclusionACHD patients hospitalized for VPI have similar in-hospital mortality, but higher acute kidney injury and liver failure rates compared to the general population, highlighting the importance of vaccination in this vulnerable patient group.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.